|
SUPT4H1 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.717300E-03 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.738200E-02 |
| Normal-vs-Stage2 |
5.638300E-03 |
| Normal-vs-Stage3 |
1.477550E-03 |
| Normal-vs-Stage4 |
2.190300E-04 |
| Stage1-vs-Stage2 |
6.313800E-02 |
| Stage1-vs-Stage3 |
1.293980E-02 |
| Stage1-vs-Stage4 |
6.018500E-03 |
| Stage2-vs-Stage3 |
9.686600E-01 |
| Stage2-vs-Stage4 |
7.107600E-01 |
| Stage3-vs-Stage4 |
7.051000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.440000E-03 |
| Normal-vs-AfricanAmerican |
6.565400E-04 |
| Normal-vs-Asian |
8.573800E-01 |
| Caucasian-vs-AfricanAmerican |
8.585500E-02 |
| Caucasian-vs-Asian |
7.452800E-01 |
| AfricanAmerican-vs-Asian |
5.081600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.996610E-03 |
| Normal-vs-Female |
3.020400E-02 |
| Male-vs-Female |
1.752750E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.732000E-02 |
| Normal-vs-Age(41-60Yrs) |
3.143500E-03 |
| Normal-vs-Age(61-80Yrs) |
1.187850E-02 |
| Normal-vs-Age(81-100Yrs) |
2.415800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.098200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.516000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.255200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.548400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.532600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.800600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
8.377200E-01 |
| Normal-vs-Grade 2 |
6.748300E-02 |
| Normal-vs-Grade 3 |
2.881600E-03 |
| Normal-vs-Grade 4 |
1.396660E-04 |
| Grade 1-vs-Grade 2 |
4.814600E-01 |
| Grade 1-vs-Grade 3 |
1.972600E-01 |
| Grade 1-vs-Grade 4 |
5.091900E-02 |
| Grade 2-vs-Grade 3 |
7.305900E-02 |
| Grade 2-vs-Grade 4 |
2.196900E-03 |
| Grade 3-vs-Grade 4 |
8.836000E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
8.008800E-01 |
| Normal-vs-ccB subtype |
5.71320000000153E-05 |
| ccA subtype-vs-ccB subtype |
2.01590000026286E-07 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.550250E-02 |
| Normal-vs-N1 |
3.549200E-01 |
| N0-vs-N1 |
7.173200E-01 |
|
|
